PedAM
Pediatric Disease Annotations & Medicines
| Disease | arthritis |
| Phenotype | C0024115|lung disease |
| Sentences | 22 |
| PubMedID- 22185348 | Rheumatoid arthritis-associated interstitial lung disease (ra-ild) is associated with increased mortality in up to 10% of patients with rheumatoid arthritis. |
| PubMedID- 20884744 | lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. |
| PubMedID- 24378059 | Objective: to investigate the effect of selective phosphodiesterase (pde) 4 inhibitors on nuclear factor kappa b (nf-kappab), tumor necrosis factor-alpha (tnfalpha) and interleukin-8 (il-8) secreted by peripheral blood mononuclear cells (pbmcs) in patients diagnosed as rheumatoid arthritis with interstitial lung disease (ra-ild). |
| PubMedID- 26137341 | In the absence of active rheumatoid arthritis, patients with rheumatoid arthritis lung disease who fail to respond to therapy should be considered for lung transplant. |
| PubMedID- 20522855 | A case of debilitating cavitating lung disease associated with rheumatoid arthritis and bronchocentric granulomatosis, which failed to respond to conventional medical or surgical treatment, is described. |
| PubMedID- 21325762 | Objective: acute-onset diffuse interstitial lung disease (aodild) in patients with rheumatoid arthritis (ra) has been a serious concern, especially for those under treatment with biological agents which may affect the presentation and outcome of aodild, including pneumocystis pneumonia (pcp). |
| PubMedID- 22265461 | Rheumatoid nodules are a rare manifestation of lung disease associated with rheumatoid arthritis (ra). |
| PubMedID- 25746669 | A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in chinese patients. |
| PubMedID- 20480164 | A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab. |
| PubMedID- 22806097 | We also present a third clinical entity, that of lung disease associated with rheumatoid arthritis (rheumatoid lung), representing a condition that can manifest as either phenotype, and offering a potential opportunity to explore the mechanisms underlying the pathogenesis of the two distinct fibrotic phenotypes. |
| PubMedID- 25417684 | Abatacept therapy in rheumatoid arthritis with interstitial lung disease. |
| PubMedID- 26401101 | Management of rheumatoid arthritis patients with interstitial lung disease: safety of biological antirheumatic drugs and assessment of pulmonary fibrosis. |
| PubMedID- 25665185 | Sonographic assessment of interstitial lung disease in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus. |
| PubMedID- 24521636 | Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: a pilot study. |
| PubMedID- 25922727 | Changes in peripheral cd19(+)foxp3(+) and cd19(+)tgfbeta(+) regulatory b cell populations in rheumatoid arthritis patients with interstitial lung disease. |
| PubMedID- 25589842 | Rheumatoid arthritis-associated interstitial lung disease (ra-ild), the most common manifestation of rheumatoid lung disease [1], occurs more frequently in patients with severe ra. |
| PubMedID- 24200605 | Extra-muscular manifestations such as dermatitis, arthritis, interstitial lung disease (ild), cardiomyopathy, and enteropathy are occasional complications in patients with pm/dm. |
| PubMedID- 22341526 | Objective: to describe the evolution of lung function in a cohort of rheumatoid arthritis (ra) patients with interstitial lung disease (ild) treated according to the medical judgment of attending physicians. |
| PubMedID- 25491030 | Case presentation: case 1 is that of a 72-year-old japanese man with untreated mac lung disease, who was diagnosed with rheumatoid arthritis and initiated on methotrexate. |
| PubMedID- 25744479 | Backgrounds: interstitial lung disease (ild) is associated with rheumatoid arthritis (ra) itself and is also induced by biological and non-biological disease-modifying antirheumatic drugs. |
| PubMedID- 22084614 | We report a case of a 52-year-old woman with a 1-year history of rheumatoid arthritis-associated interstitial lung disease referred to hospital because of aggravated pulmonary symptoms in spite of intensive treatment including prednisone, azathioprine and triptergium glycoside. |
| PubMedID- 20851924 | However, mortality rates from rheumatoid arthritis-associated interstitial lung disease increased 28.3% in women (to 3.1 per million persons in 2004) and declined 12.5% in men (to 1.5 per million persons in 2004). |
Page: 1